The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 186.10
Bid: 186.50
Ask: 186.80
Change: 3.20 (1.75%)
Spread: 0.30 (0.161%)
Open: 182.80
High: 187.60
Low: 182.80
Prev. Close: 182.90
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

18 Oct 2023 14:13

RNS Number : 5659Q
Ashmore Group PLC
18 October 2023
 

Ashmore Group plc (the "Company")

18 October 2023

 

RESULTS OF ANNUAL GENERAL MEETING ("AGM")

 

The Board of Ashmore Group plc is pleased to announce that at the AGM of the Company held earlier today all resolutions were duly passed on a poll. All of the resolutions are accordingly declared as carried. Resolutions 5, 6, 7, 8 and 9, relating to the election and re-election of Independent Non-Executive Directors, are carried by a majority of votes cast by both independent shareholders as well as by a majority of votes cast by all shareholders.

 

The results of the poll on each resolution were as follows:

 

 

FOR

AGAINST

ABSTAIN*

TOTAL VOTE

 

 

% age of total votes in favour

 

Resolution

 

No. of Votes

 

No. of Votes

 

No. of Votes

 

 

1

 

To receive and adopt the report and accounts for the year ended 30 June 2023

579,076,136

275

1,778,890

579,076,411

100.00

2

To declare a final dividend for the year ended 30 June 2023 of 12.1 pence per Ordinary Share

579,462,596

1,391,681

1,024

580,854,277

99.76

3

To re-elect Mark Coombs as a Director

580,802,028

44,115

9,158

580,846,143

99.99

4

To re-elect Tom Shippey as a Director

580,746,708

99,435

9,158

580,846,143

99.98

5

To re-elect Clive Adamson as a Director (all shareholders)

575,736,381

3,567,233

1,551,687

579,303,614

99.38

5

To re-elect Clive Adamson as a Director (independent shareholders)

353,300,846

3,567,233

1,551,687

356,868,079

99.00

6

To re-elect Helen Beck as a Director (all shareholders)

574,647,536

6,198,415

9,350

580,845,951

98.93

6

To re-elect Helen Beck as a Director (independent shareholders)

352,212,001

6,198,415

9,350

358,410,416

98.27

7

To re-elect Jennifer Bingham as a Director (all shareholders)

564,992,903

15,853,048

9,350

580,845,951

97.27

7

To re-elect Jennifer Bingham as a Director (independent shareholders)

342,557,368

15,853,048

9,350

358,410,416

95.58

8

To re-elect Shirley Garrood as a Director (all shareholders)

578,487,003

2,358,948

9,350

580,845,951

99.59

8

To re-elect Shirley Garrood as a Director (independent shareholders)

356,051,468

2,358,948

9,350

358,410,416

99.34

9

To elect Thuy Dam as a Director (all shareholders)

580,839,495

8,994

6,812

580,848,489

100.00

9

To elect Thuy Dam as a Director (independent shareholders)

358,403,960

8,994

6,812

358,412,954

100.00

10

To approve the remuneration policy

477,407,150

66,158,484

37,289,667

543,565,634

87.83

11

To approve the remuneration report for the year ended 30 June 2023

505,993,326

37,591,318

37,270,657

543,584,644

93.08

12

To appoint Ernst & Young LLP as auditors

579,276,909

1,571,180

7,212

580,848,089

99.73

13

To authorise the Audit and Risk Committee to agree the remuneration of the auditors

580,812,606

16,110

26,585

580,828,716

100.00

14

To authorise political donations and political expenditure

569,930,037

10,915,364

9,900

580,845,401

98.12

15

To authorise the Directors to allot shares

566,729,134

14,101,376

24,791

580,830,510

97.57

16

To authorise the dis-application of pre-emption rights up to 35,637,040 shares**

573,752,340

7,078,310

24,651

580,830,650

98.78

17

To authorise the dis-application of pre-emption rights up to a further 35,637,040 shares**

568,203,346

12,627,304

24,651

580,830,650

97.83

18

To authorise market purchases of shares**

570,362,942

10,390,594

101,765

580,753,536

98.21

19

To approve the renewal of the waiver of the obligation under Rule 9 of the Takeover Code***

344,863,998

11,942,016

1,613,752

356,806,014

96.65

20

To reduce the notice period for general meetings other than an annual general meeting**

573,026,372

7,806,056

22,873

580,832,428

98.66

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.

 

** Indicates Special Resolutions requiring a 75% majority.

*** Mark Coombs has not voted on Resolution 19 as an interested party.

 

Ashmore Group plc's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

In accordance with LR 9.6.2R, copies of resolutions concerning special business passed at the AGM today have been submitted to the Financial Conduct Authority's national storage mechanism. This document will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information, please contact:

 

Ashmore Group plc

Paul Measday

Investor Relations +44 (0)20 3077 6278

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGMPBJTMTBBBTJ
Date   Source Headline
18th Apr 20241:11 pmRNSDirectorate Change
15th Apr 20247:00 amRNSTrading Statement
18th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:30 amRNSHolding(s) in Company
11th Dec 202311:21 amRNSDirector/PDMR Shareholding
18th Oct 20232:13 pmRNSResult of AGM
13th Oct 20237:00 amRNSTrading Statement
19th Sep 202311:00 amRNSDirector/PDMR Shareholding
19th Sep 202310:08 amRNSHolding(s) in Company
15th Sep 20235:06 pmRNSHolding(s) in Company
14th Sep 20232:56 pmRNSNotice of AGM
14th Sep 202310:29 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSFinal Results
14th Jul 20231:51 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSTrading Statement
11th Jul 20232:10 pmRNSHolding(s) in Company
10th Jul 20232:48 pmRNSHolding(s) in Company
30th Jun 20235:11 pmRNSHolding(s) in Company
29th Jun 20239:09 amRNSHolding(s) in Company
14th Jun 20239:23 amRNSHolding(s) in Company
19th May 20238:35 amRNSDirector Declaration
21st Apr 20237:00 amRNSDirectorate Change
17th Apr 20237:00 amRNSTrading Statement
14th Apr 20239:30 amRNSAGM Statement
31st Mar 20232:33 pmRNSDirector/PDMR Shareholding
17th Mar 202310:21 amRNSDirector/PDMR Shareholding
13th Mar 202310:23 amRNSAudit tender process
8th Mar 20239:48 amRNSHolding(s) in Company
27th Feb 20239:41 amRNSHolding(s) in Company
16th Feb 20234:53 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:02 pmRNSHolding(s) in Company
25th Jan 20233:25 pmRNSHolding(s) in Company
24th Jan 20236:12 pmRNSHolding(s) in Company
23rd Jan 20239:01 amRNSHolding(s) in Company
19th Jan 20234:55 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Statement
12th Jan 20233:26 pmRNSHolding(s) in Company
11th Jan 20234:27 pmRNSHolding(s) in Company
9th Jan 20233:13 pmRNSHolding(s) in Company
5th Jan 20235:14 pmRNSHolding(s) in Company
16th Dec 20223:52 pmRNSHolding(s) in Company
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.